Safety, Tolerability and Pharmacokinetic‑Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo‑Controlled, Double‑Blind, Multiple Ascending Dose Study

ORIGINAL RESEARCH article

Neurology and Therapy 2024

Annette Janus¹ · Daniel Dumas^2,3 · Juliette Le Douce¹ · Sébastien Marie¹ · Giuseppe Pasculli⁴ · Pauline Bambury⁴ · Sighild Lemarchant¹ · Philip Kremer^2,3 · Yann Godfrin^1,5

1. Axoltis Pharma, 60 Avenue Rockefeller, 69008 Lyon, France.
2. Centre for Human Drug Research (CHDR), Leiden, The Netherlands
3. Leiden University Medical Centre (LUMC), Leiden, The Netherlands
4. InSilicoTrials Technologies, Trieste, Italy
5. Godfrin Life‐Sciences, 8 Impasse de la Source, 69300 Caluire‐et‐Cuire, France

PDF version